Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arenillas

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Neurologia (Barcelona, Spain)|May 4, 2016
Criteria for training and accreditation in Interventional Neuroradiology-Neurointervention, approved by the Spanish Group of Interventional Neuroradiology (GENI), the Spanish Society of Neuroradiology (SENR), the Spanish Group of Cerebrovascular Diseases (GEECV), the Spanish Society of Neurology (SEN), and the vascular disease specialists in the Spanish Society of Neurosurgery (SENEC). Requirements for accreditation in Interventional Neuroradiology-Neurointervention for institutions and specialistsF Fortea, J Masjuan, F Arikán-Abello, et al.
Genome Biology|April 24, 2015
Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomasAnthony Mathelier, Calvin Lefebvre, Allen W Zhang, et al.
Revista De Neurologia|September 20, 2001
[Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke]J Montaner, J Alvarez-Sabín, G Barberá, et al.
Nucleic Acids Research|June 4, 2005
oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genesShannan J Ho Sui, James R Mortimer, David J Arenillas, et al.
Neurologia|December 15, 2021
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidanceA Gil-Núñez, J Masjuan, J Montaner, et al.
Neurologia|December 28, 2020
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidanceA Gil-Núñez, J Masjuan, J Montaner, et al.
Neurologia (Barcelona, Spain)|October 3, 2009
[Necessary components in the hospitals that attend patients with stroke: results of a survey of Spanish experts]José Alvarez-Sabín, J Masjuan, M Alonso de Leciñana, et al.
Nucleic Acids Research|May 11, 2023
OnTarget: in silico design of MiniPromoters for targeted delivery of expressionOriol Fornes, Tamar V Av-Shalom, Andrea J Korecki, et al.
Human Mutation|February 24, 2015
GeneYenta: a phenotype-based rare disease case matching tool based on online dating algorithms for the acceleration of exome interpretationMichael M Gottlieb, David J Arenillas, Savanie Maithripala, et al.
Molecular Biosystems|April 22, 2009
Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cellsNeeloffer Mookherjee, Pamela Hamill, Jennifer Gardy, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Neurologia (Barcelona, Spain)|May 4, 2016
Criteria for training and accreditation in Interventional Neuroradiology-Neurointervention, approved by the Spanish Group of Interventional Neuroradiology (GENI), the Spanish Society of Neuroradiology (SENR), the Spanish Group of Cerebrovascular Diseases (GEECV), the Spanish Society of Neurology (SEN), and the vascular disease specialists in the Spanish Society of Neurosurgery (SENEC). Requirements for accreditation in Interventional Neuroradiology-Neurointervention for institutions and specialistsF Fortea, J Masjuan, F Arikán-Abello, et al.
Genome Biology|April 24, 2015
Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomasAnthony Mathelier, Calvin Lefebvre, Allen W Zhang, et al.
Revista De Neurologia|September 20, 2001
[Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke]J Montaner, J Alvarez-Sabín, G Barberá, et al.
Nucleic Acids Research|June 4, 2005
oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genesShannan J Ho Sui, James R Mortimer, David J Arenillas, et al.
Neurologia|December 15, 2021
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidanceA Gil-Núñez, J Masjuan, J Montaner, et al.
Neurologia|December 28, 2020
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidanceA Gil-Núñez, J Masjuan, J Montaner, et al.
Neurologia (Barcelona, Spain)|October 3, 2009
[Necessary components in the hospitals that attend patients with stroke: results of a survey of Spanish experts]José Alvarez-Sabín, J Masjuan, M Alonso de Leciñana, et al.
Nucleic Acids Research|May 11, 2023
OnTarget: in silico design of MiniPromoters for targeted delivery of expressionOriol Fornes, Tamar V Av-Shalom, Andrea J Korecki, et al.
Human Mutation|February 24, 2015
GeneYenta: a phenotype-based rare disease case matching tool based on online dating algorithms for the acceleration of exome interpretationMichael M Gottlieb, David J Arenillas, Savanie Maithripala, et al.
Molecular Biosystems|April 22, 2009
Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cellsNeeloffer Mookherjee, Pamela Hamill, Jennifer Gardy, et al.
Pageof 4